Role of lipid rafts in the processing of the pathogenic prion and Alzheimer's amyloid-β proteins

Seminars in Cell and Developmental Biology

Volumn 18, Issue 5, 2007, Pages 638-648

  Taylor, David R ^a   Hooper, Nigel M ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Alzheimer; Amyloid; Cholesterol; Lipid raft; Prion

Indexed keywords

AMYLOID BETA PROTEIN; BETA SECRETASE; CHOLINESTERASE INHIBITOR; FILIPIN; FUMONISIN B1; MEMANTINE; METHYL BETA CYCLODEXTRIN; MEVINOLIN; PRION PROTEIN; SIMVASTATIN; SQUALESTATIN; THY 1 ANTIGEN;

ALZHEIMER DISEASE; CELL SURFACE; CHOLESTEROL SYNTHESIS; CREUTZFELDT JAKOB DISEASE; CROSS LINKING; DRUG INHIBITION; DRUG MECHANISM; ENDOCYTOSIS; EXOSOME; GOLGI COMPLEX; HUMAN; LIPID RAFT; NONHUMAN; PATHOGENESIS; PRION DISEASE; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; SURVIVAL TIME;

EID: 35648990044     PISSN: 10849521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcdb.2007.07.008     Document Type: Review

References (135)

1. Singer S.J., and Nicolson G.L. The fluid mosaic model of the structure of cell membranes. Science 175 (1972) 720-731
2. Engelman D.M. Membranes are more mosaic than fluid. Nature 438 (2005) 578-580
3. Simons K., and Ikonen E. Functional rafts in cell membranes. Nature 387 (1997) 569-572
4. Brown D.A., and London E. Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J Biol Chem 275 (2000) 17221-17224
5. Brown D.A., and Rose J.K. Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell 68 (1992) 533-544
6. Lichtenberg D., Goni F.M., and Heerklotz H. Detergent-resistant membranes should not be identified with membrane rafts. Trends Biochem Sci 30 (2005) 430-436
7. Hooper N.M. Detergent-insoluble glycosphingolipid/cholesterol-rich membrane domains, lipid rafts and caveolae. Mol Membr Biol 16 (1999) 145-156
8. Simons K., and Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 1 (2000) 31-39
9. Manes S., del Real G., and Martinez A.C. Pathogens: raft hijackers. Nat Rev Immunol 3 (2003) 557-568
10. Reig N., and van der Goot F.G. About lipids and toxins. FEBS Lett 580 (2006) 5572-5579
11. Shogomori H., and Futerman A.H. Cholera toxin is found in detergent-insoluble rafts/domains at the cell surface of hippocampal neurons but is internalized via a raft-independent mechanism. J Biol Chem 276 (2001) 9182-9188
12. Abrami L., Liu S., Cosson P., Leppla S.H., and van der Goot F. Anthrax toxin triggers endocytosis of its receptor via a lipid raft-mediated clathrin-dependent process. J Cell Biol 160 (2003) 321-328
13. Scheiffele P., Rietveld A., Wilk T., and Simons K. Influenza viruses select ordered lipid domains during budding from the plasma membrane. J Biol Chem 274 (1999) 2038-2044
14. Nguyen D.H., and Hildreth J.E. Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J Virol 74 (2000) 3264-3272
15. Prusiner S.B. Prions. Proc Natl Acad Sci USA 95 (1998) 13363-13383
16. Donne D.G., Viles J.H., Groth D., Mehlhorn I., James T.L., Cohen F.E., et al. Structure of the recombinant full-length hamster prion protein PrP(29-231): the N terminus is highly flexible. Proc Natl Acad Sci USA 94 (1997) 13452-13457
17. Zahn R., Liu A., Luhrs T., Riek R., von Schroetter C., Lopez Garcia F., et al. NMR solution structure of the human prion protein. Proc Natl Acad Sci USA 97 (2000) 145-150
18. Bueler H., Aguzzi A., Sailer A., Greiner R.A., Autenried P., Aguet M., et al. Mice devoid of PrP are resistant to scrapie. Cell 73 (1993) 1339-1347
19. Milhavet O., and Lehmann S. Oxidative stress and the prion protein in transmissible spongiform encephalopathies. Brain Res Brain Res Rev 38 (2002) 328-339
20. Perera W.S.S., and Hooper N.M. Ablation of the metal ion-induced endocytosis of the prion protein by disease-associated mutation of the octarepeat region. Curr Biol 11 (2001) 519-523
21. Watt N.T., and Hooper N.M. The prion protein and neuronal zinc homeostasis. Trends Biochem Sci 28 (2003) 406-410
22. Mouillet-Richard S., Ermonval M., Chebassier C., Laplanche J.L., Lehmann S., Launay J.M., et al. Signal transduction through prion protein. Science 289 (2000) 1925-1928
23. Collinge J., Whittington M.A., Sidle K.C., Smith C.J., Palmer M.S., Clarke A.R., et al. Prion protein is necessary for normal synaptic function. Nature 370 (1994) 295-297
24. Taraboulos A., Scott M., Semenov A., Avraham D., Laszlo L., and Prusiner S.B. Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform. J Cell Biol 129 (1995) 121-132
25. Vey M., Pilkuhn S., Wille H., Nixon R., DeArmond S.J., Smart E.J., et al. Subcellular colocalization of the cellular and scrapie prion proteins in caveolae-like membranous domains. Proc Natl Acad Sci USA 93 (1996) 14945-14949
26. Naslavsky N., Stein R., Yanai A., Friedlander G., and Taraboulos A. Characterization of detergent-insoluble complexes containing the cellular prion protein and its scrapie isoform. J Biol Chem 272 (1997) 6324-6331
27. C association with lipid rafts in the early secretory pathway stabilizes its cellular conformation. Mol Biol Cell 15 (2004) 4031-4042
28. Gilch S., Kehler C., and Schatzl H.M. The prion protein requires cholesterol for cell surface localization. Mol Cell Neurosci 31 (2006) 346-353
29. Madore N., Smith K.L., Graham C.H., Jen A., Brady K., Hall S., et al. Functionally different GPI proteins are organised in different domains on the neuronal surface. EMBO J 19 (1999) 6917-6926
30. Brugger B., Graham C., Leibrecht I., Mombelli E., Jen A., Wieland F., et al. The membrane domains occupied by glycosylphosphatidylinositol-anchored prion protein and Thy-1 differ in lipid composition. J Biol Chem 279 (2004) 7530-7536
31. Stahl N., Borchelt D.R., Hsiao K., and Prusiner S.B. Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell 51 (1987) 229-240
32. Walmsley A.R., Zeng F., and Hooper N.M. The N-terminal region of the prion protein ectodomain contains a lipid raft targeting determinant. J Biol Chem 278 (2003) 37241-37248
33. Baron G.S., and Caughey B. Effect of glycosylphosphatidylinositol anchor-dependent and -independent prion protein association with model raft membranes on conversion to the protease-resistant isoform. J Biol Chem 278 (2003) 14883-14892
34. Mahfoud R., Garmy N., Maresca M., Yahi N., Puigserver A., and Fantini J. Identification of a common sphingolipid-binding domain in Alzheimer, prion, and HIV-1 proteins. J Biol Chem 277 (2002) 11292-11296
35. Stahl N., Baldwin M.A., Burlingame A.L., and Prusiner S.B. Identification of glycoinositol phospholipid linked and truncated forms of the scrapie prion protein. Biochemistry 29 (1990) 8879-8884
36. Gabizon R., McKinley M.P., and Prusiner S.B. Purified prion proteins and scrapie infectivity copartition into liposomes. Proc Natl Acad Sci USA 84 (1987) 4017-4021
37. Kaneko K., Vey M., Scott M., Pilkuhn S., Cohen F.E., and Prusiner S.B. COOH-terminal sequence of the cellular prion protein directs subcellular trafficking and controls conversion iinto the scapie isoform. Proc Natl Acad Sci USA 94 (1997) 2333-2338
38. Marella M., Lehmann S., Grassi J., and Chabry J. Filipin prevents pathological prion protein accumulation by reducing endocytosis and inducing cellular PrP release. J Biol Chem 277 (2002) 25457-25464
39. Bate C., Salmona M., Diomede L., and Williams A. Squalestatin cures prion-infected neurons and protects against prion neurotoxicity. J Biol Chem 279 (2004) 14983-14990
40. Naslavsky N., Shmeeda H., Friedlander G., Yanai A., Futerman A.H., Barenholz Y., et al. Sphingolipid depletion increases formation of the scrapie prion protein in neuroblastoma cells infected with prions. J Biol Chem 274 (1999) 20763-20771
41. Mok S.W., Thelen K.M., Riemer C., Bamme T., Gultner S., Lutjohann D., et al. Simvastatin prolongs survival times in prion infections of the central nervous system. Biochem Biophys Res Commun 348 (2006) 697-702
42. Sc) into contiguous membranes. EMBO J 21 (2002) 1031-1040
43. Kanu N., Imokawa Y., Drechsel D.N., Williamson R.A., Birkett C.R., Bostock C.J., et al. Transfer of scrapie prion infectivity by cell contact in culture. Curr Biol 12 (2002) 523-530
44. Nishina K., Deleault N.R., Lucassen R.W., and Supattapone S. In vitro prion protein conversion in detergent-solubilized membranes. Biochemistry 43 (2004) 2613-2621
45. Borchelt D.R., Rogers M., Stahl N., Telling G., and Prusiner S.B. Release of the cellular prion protein from cultured cells after loss of its glycoinositol phospholipid anchor. Glycobiology 3 (1993) 319-329
46. Parkin E.T., Watt N.T., Turner A.J., and Hooper N.M. Dual mechanisms for shedding of the cellular prion protein. J Biol Chem 279 (2004) 11170-11178
47. Parizek P., Roeckl C., Weber J., Flechsig E., Aguzzi A., and Raeber A.J. Similar turnover and shedding of the cellular prion protein in primary lymphoid and neuronal cells. J Biol Chem 276 (2001) 44627-44632
48. Fevrier B., Vilette D., Archer F., Loew D., Faigle W., Vidal M., et al. Cells release prions in association with exosomes. Proc Natl Acad Sci USA 101 (2004) 9683-9688
49. Chesebro B., Trifilo M., Race R., Meade-White K., Teng C., LaCasse R., et al. Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science 308 (2005) 1435-1439
50. Campana V., Sarnataro D., and Zurzolo C. The highways and byways of prion protein trafficking. Trends Cell Biol 15 (2005) 102-111
51. Borchelt D.R., Taraboulos A., and Prusiner S.B. Evidence for synthesis of scrapie prion proteins in the endocytic pathway. J Biol Chem 267 (1992) 16188-16199
52. Taraboulos A., Raeber A.J., Borchelt D.R., Serban D., and Prusiner S.B. Synthesis and trafficking of prion proteins in cultured cells. Mol Biol Cell 3 (1992) 851-863
53. Arnold J.E., Tipler C., Laszlo L., Hope J., Landon M., and Mayer R.J. The abnormal isoform of the prion protein accumulates in late-endosome-like organelles in scrapie-infected mouse brain. J Pathol 176 (1995) 403-411
54. Peters P.J., Mironov Jr. A., Peretz D., van Donselaar E., Leclerc E., Erpel S., et al. Trafficking of prion proteins through a caveolae-mediated endosomal pathway. J Cell Biol 162 (2003) 703-717
55. Gorodinsky A., and Harris D.A. Glycolipid-anchored proteins in neuroblastoma cells form detergent-resistant complexes without caveolin. J Cell Biol 129 (1995) 619-627
56. Shyng S.L., Heuser J.E., and Harris D.A. A glycolipid-anchored prion protein is endocytosed via clathrin-coated pits. J Cell Biol 125 (1994) 1239-1250
57. Sunyach C., Jen A., Deng J., Fitzgerald K.T., Frobert Y., Grassi J., et al. The mechanism of internalization of glycosylphosphatidylinositol-anchored prion protein. EMBO J 22 (2003) 3591-3601
58. Taylor D.R., Watt N.T., Perera W.S., and Hooper N.M. Assigning functions to distinct regions of the N-terminus of the prion protein that are involved in its copper-stimulated, clathrin-dependent endocytosis. J Cell Sci 118 (2005) 5141-5153
59. Lee K.S., Linden R., Prado M.A., Brentani R.R., and Martins V.R. Towards cellular receptors for prions. Rev Med Virol 13 (2003) 399-408
60. Taylor D.R., and Hooper N.M. The low-density lipoprotein receptor-related protein 1 (LRP1) mediates the endocytosis of the cellular prion protein. Biochem J 402 (2007) 17-23
61. Santuccione A., Sytnyk V., Leshchyns'ka I., and Schachner M. Prion protein recruits its neuronal receptor NCAM to lipid rafts to activate p59fyn and to enhance neurite outgrowth. J Cell Biol 169 (2005) 341-354
62. Horonchik L., Tzaban S., Ben-Zaken O., Yedidia Y., Rouvinski A., Papy-Garcia D., et al. Heparan sulfate is a cellular receptor for purified infectious prions. J Biol Chem 280 (2005) 17062-17067
63. Gauczynski S., Peyrin J.M., Haik S., Leucht C., Hundt C., Rieger R., et al. The 37-kDa/67-kDa laminin receptor acts as the cell-surface receptor for the cellular prion protein. EMBO J 20 (2001) 5863-5875
64. Gauczynski S., Nikles D., El-Gogo S., Papy-Garcia D., Rey C., Alban S., et al. The 37-kDa/67-kDa laminin receptor acts as a receptor for infectious prions and is inhibited by polysulfated glycanes. J Infect Dis 194 (2006) 702-709
65. Kazlauskaite J., Sanghera N., Sylvester I., Venien-Bryan C., and Pinheiro T.J. Structural changes of the prion protein in lipid membranes leading to aggregation and fibrillization. Biochemistry 42 (2003) 3295-3304
66. Sanghera N., and Pinheiro T.J. Binding of prion protein to lipid membranes and implications for prion conversion. J Mol Biol 315 (2002) 1241-1256
67. Critchley P., Kazlauskaite J., Eason R., and Pinheiro T.J. Binding of prion proteins to lipid membranes. Biochem Biophys Res Commun 313 (2004) 559-567
68. Hardy J. A hundred years of Alzheimer's disease research. Neuron 52 (2006) 3-13
69. Vardy E.R., Hussain I., and Hooper N.M. Emerging therapeutics for Alzheimer's disease. Expert Rev Neurother 6 (2006) 695-704
70. Taylor J.P., Hardy J., and Fischbeck K.H. Toxic proteins in neurodegenerative disease. Science 296 (2002) 1991-1995
71. Vardy E.R.L.C., Catto A.J., and Hooper N.M. Proteolytic mechanisms in amyloid-β metabolism: therapeutic implications for Alzheimer's disease. Trends Mol Med 11 (2005) 464-472
72. Esler W.P., and Wolfe M.S. A portrait of Alzheimer secretases-new features and familiar faces. Science 293 (2001) 1449-1454
73. Haass C. Take five-BACE and the gamma-secretase quartet conduct Alzheimer's amyloid beta-peptide generation. EMBO J 23 (2004) 483-488
74. Barger S.W., and Harmon A.D. Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature 388 (1997) 878-881
75. Meziane H., Dodart J.-C., Mathis C., Little S., Clemens J., Paul S.M., et al. Memory-enhancing effects of secreted forms of the β-amyloid precursor protein in normal and amnestic mice. Proc Natl Acad Sci USA 95 (1998) 12683-12688
76. Hooper N.M., and Turner A.J. The search for α-secretase and its potential as a therapeutic approach to Alzheimer's disease. Curr Med Chem 9 (2002) 1107-1119
77. Allinson T.M., Parkin E.T., Turner A.J., and Hooper N.M. ADAMs family members as amyloid precursor protein α-secretases. J Neurosci Res 74 (2003) 342-352
78. Naus S., Reipschlager S., Wildeboer D., Lichtenthaler S.F., Mitterreiter S., Guan Z., et al. Identification of candidate substrates for ectodomain shedding by the metalloprotease-disintegrin ADAM8. Biol Chem 387 (2006) 337-346
79. Tanabe C., Hotoda N., Sasagawa N., Sehara-Fujisawa A., Maruyama K., and Ishiura S. ADAM19 is tightly associated with constitutive Alzheimer's disease APP α-secretase in A172 cells. Biochem Biophys Res Commun 352 (2007) 111-117
80. Sparks D.L., Hunsaker III J.C., Scheff S.W., Kryscio R.J., Henson J.L., et al. Cortical senile plaques in coronary artery disease, aging and Alzheimer's disease. Neurobiol Aging 11 (1990) 601-607
81. Kivipelto M., Helkala E.L., Laakso M.P., Hanninen T., Hallikainen M., Alhainen K., et al. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ 322 (2001) 1447-1451
82. Kivipelto M., Helkala E.L., Laakso M.P., Hanninen T., Hallikainen M., Alhainen K., et al. Apolipoprotein E ε4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease. Ann Intern Med 137 (2002) 149-155
83. Notkola I.L., Sulkava R., Pekkanen J., Erkinjuntti T., Ehnholm C., Kivinen P., et al. Serum total cholesterol, apolipoprotein E ε4 allele, and Alzheimer's disease. Neuroepidemiology 17 (1998) 14-20
84. Pappolla M.A., Bryant-Thomas T.K., Herbert D., Pacheco J., Fabra Garcia M., Manjon M., et al. Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology. Neurology 61 (2003) 199-205
85. Jick H., Zornberg G.L., Jick S.S., Seshadri S., and Drachman D.A. Statins and the risk of dementia. Lancet 356 (2000) 1627-1631
86. Wolozin B., Kellman W., Ruosseau P., Celesia G.G., and Siegel G. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch Neurol 57 (2000) 1439-1443
87. Sparks D.L., Sabbagh M.N., Connor D.J., Lopez J., Launer L.J., Browne P., et al. Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results. Arch Neurol 62 (2005) 753-757
88. Simons M., Schwarzler F., Lutjohann D., von Bergmann K., Beyreuther K., Dichgans J., et al. Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: a 26-week randomized, placebo-controlled, double-blind trial. Ann Neurol 52 (2002) 346-350
89. Shepherd J., Blauw G.J., Murphy M.B., Bollen E.L., Buckley B.M., Cobbe S.M., et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 360 (2002) 1623-1630
90. Refolo L.M., Pappolla M.A., Malester B., LaFrancois J., Bryant-Thomas T., Wang R., et al. Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model. Neurobiol Dis 7 (2000) 321-331
91. Ghribi O., Larsen B., Schrag M., and Herman M.M. High cholesterol content in neurons increases BACE, β-amyloid, and phosphorylated tau levels in rabbit hippocampus. Exp Neurol 200 (2006) 460-467
92. Fassbender K., Simons M., Bergmann C., Stroick M., Lutjohann D., Keller P., et al. Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ 42 and Aβ 40 in vitro and in vivo. Proc Natl Acad Sci USA 98 (2001) 5856-5861
93. Refolo L.M., Pappolla M.A., LaFrancois J., Malester B., Schmidt S.D., Thomas-Bryant T., et al. A cholesterol-lowering drug reduces β-amyloid pathology in a transgenic mouse model of Alzheimer's disease. Neurobiol Dis 8 (2001) 890-899
94. Simons M., Keller P., De Strooper B., Beyreuther K., Dotti C.G., and Simons K. Cholesterol depletion inhibits the generation of β-amyloid in hippocampal neurons. Proc Natl Acad Sci USA 95 (1998) 6460-6464
95. Frears E.R., Stephens D.J., Walters C.E., Davies H., and Austen B.M. The role of cholesterol in the biosynthesis of β-amyloid. NeuroReport 10 (1999) 1699-1705
96. Caporaso G.L., Gandy S.E., Buxbaum J.D., Ramabhadran T.V., and Greengard P. Protein phosphorylation regulates secretion of Alzheimer β/A4 amyloid precursor protein. Proc Natl Acad Sci USA 89 (1992) 3055-3059
97. Hung A.Y., Haass C., Nitsch R.M., Qiu W.Q., Citron M., Wurtman R.J., et al. Activation of protein kinase C inhibits cellular production of the amyloid β-protein. J Biol Chem 268 (1993) 22959-22962
98. Savage M.J., Trusko S.P., Howland D.S., Pinsker L.R., Mistretta S., Reaume A.G., et al. Turnover of amyloid β-protein in mouse brain and acute reduction of its level by phorbol ester. J Neurosci 18 (1998) 1743-1752
99. Lee S.-J., Liyanage U., Bickel P.E., Xia W., Lansbury P.T.J., and Kosik K.S. A detergent-insoluble membrane compartment contains Aβ in vivo. Nat Med 4 (1998) 730-734
100. Parkin E.T., Hussain I., Karran E.H., Turner A.J., and Hooper N.M. Characterisation of detergent-insoluble complexes containing the familial Alzheimer's disease-associated presenilins. J Neurochem 72 (1999) 1534-1543
101. Wahrle S., Das P., Nyborg A.C., McLendon C., Shoji M., Kawarabayashi T., et al. Cholesterol-dependent γ-secretase activity in buoyant cholesterol-rich membrane microdomains. Neurobiol Dis 9 (2002) 11-23
102. Vetrivel K.S., Cheng H., Lin W., Sakurai T., Li T., Nukina N., et al. Association of γ-secretase with lipid rafts in post-Golgi and endosome membranes. J Biol Chem 279 (2004) 44945-44954
103. Urano Y., Hayashi I., Isoo N., Reid P.C., Shibasaki Y., Noguchi N., et al. Association of active γ-secretase complex with lipid rafts. J Lipid Res 46 (2005) 904-912
104. Vetrivel K.S., Cheng H., Kim S.-H., Chen Y., Barnes N.Y., Parent A.T., et al. Spatial segregation of γ-secretase and substrates in distinct membrane domains. J Biol Chem 280 (2005) 25892-25900
105. Riddell D.R., Christie G., Hussain I., and Dingwall C. Compartmentalization of β-secretase (Asp2) into low-buoyant density, noncaveolar lipid rafts. Curr Biol 11 (2001) 1288-1293
106. Cordy J.M., Hussain I., Dingwall C., Hooper N.M., and Turner A.J. Exclusively targeting β-secretase to lipid rafts by GPI-anchor addition up-regulates β-site processing of the amyloid precursor protein. Proc Natl Acad Sci USA 100 (2003) 11735-11740
107. Kalvodova L., Kahya N., Schwille P., Ehehalt R., Verkade P., Drechsel D., et al. Lipids as modulators of proteolytic activity of BACE: involvement of cholesterol, glycosphingolipids, and anionic phospholipids in vitro. J Biol Chem 280 (2005) 36815-36823
108. Bouillot C., Prochiantz A., Rougon G., and Allinquant B. Axonal amyloid precursor protein expressed by neurons in vitro is present in a membrane fraction with caveolae-like properties. J Biol Chem 271 (1996) 7640-7644
109. Parkin E.T., Turner A.J., and Hooper N.M. Amyloid precursor protein, although partially detergent-insoluble in mouse cerebral cortex, behaves as an atypical lipid raft protein. Biochem J 344 (1999) 23-30
110. Ehehalt R., Keller P., Haass C., Thiele C., and Simons K. Amyloidogenic processing of the Alzheimer β-amyloid precursor protein depends on lipid rafts. J Cell Biol 160 (2003) 113-123
111. Parvathy S., Hussain I., Karran E.H., Turner A.J., and Hooper N.M. Cleavage of the Alzheimer's amyloid precursor protein by α-secretase occurs at the surface of neuronal cells. Biochemistry 38 (1999) 9728-9734
112. Pralle A., Keller P., Florin E.L., Simons K., and Horber J.K. Sphingolipid-cholesterol rafts diffuse as small entities in the plasma membrane of mammalian cells. J Cell Biol 148 (2000) 997-1008
113. Howland D.S., Trusko S.P., Savage M.J., Reaume A.G., Lang D.M., Hirsch J.D., et al. Modulation of secreted β-amyloid precursor protein and amyloid β-peptide in brain by cholestrol. J Biol Chem 273 (1998) 16576-16582
114. Bodovitz S., and Klein W.L. Cholesterol modulates α-secretase cleavage of amyloid precursor protein. J Biol Chem 271 (1996) 4436-4440
115. Kojro E., Gimpl G., Lammich S., Marz W., and Fahrenholz F. Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the α-secretase ADAM 10. Proc Natl Acad Sci USA 98 (2001) 5815-5820
116. von Tresckow B., Kallen K.J., von Strandmann E.P., Borchmann P., Lange H., Engert A., et al. Depletion of cellular cholesterol and lipid rafts increases shedding of CD30. J Immunol 172 (2004) 4324-4331
117. Tellier E., Canault M., Rebsomen L., Bonardo B., Juhan-Vague I., Nalbone G., et al. The shedding activity of ADAM17 is sequestered in lipid rafts. Exp Cell Res 312 (2006) 3969-3980
118. Abad-Rodriguez J., Ledesma M.D., Craessaerts K., Perga S., Medina M., Delacourte A., et al. Neuronal membrane cholesterol loss enhances amyloid peptide generation. J Cell Biol 167 (2004) 953-960
119. Ledesma M.D., and Dotti C.G. Amyloid excess in Alzheimer's disease: what is cholesterol to be blamed for?. FEBS Lett 580 (2006) 5525-5532
120. Ledesma M.D., Abad-Rodriguez J., Galvan C., Biondi E., Navarro P., Delacourte A., et al. Raft disorganization leads to reduced plasmin activity in Alzheimer's disease brains. EMBO Rep 4 (2003) 1190-1196
121. Kern A., Roempp B., Prager K., Walter J., and Behl C. Down-regulation of endogenous amyloid precursor protein processing due to cellular aging. J Biol Chem 281 (2006) 2405-2413
122. Crameri A., Biondi E., Kuehnle K., Lutjohann D., Thelen K.M., Perga S., et al. The role of seladin-1/DHCR24 in cholesterol biosynthesis, APP processing and Aβ generation in vivo. EMBO J 25 (2006) 432-443
123. Cleary J.P., Walsh D.M., Hofmeister J.J., Shankar G.M., Kuskowski M.A., Selkoe D.J., et al. Natural oligomers of the amyloid-β protein specifically disrupt cognitive function. Nat Neurosci 8 (2005) 79-84
124. Lesne S., Koh M.T., Kotilinek L., Kayed R., Glabe C.G., Yang A., et al. A specific amyloid-β protein assembly in the brain impairs memory. Nature 440 (2006) 352-357
125. Yanagisawa K., Odaka A., Suzuki N., and Ihara Y. GM1 ganglioside-bound amyloid β-protein (Aβ): a possible form of preamyloid in Alzheimer's disease. Nat Med 1 (1995) 1062-1066
126. Choo-Smith L.P., Garzon-Rodriguez W., Glabe C.G., and Surewicz W.K. Acceleration of amyloid fibril formation by specific binding of Aβ-(1-40) peptide to ganglioside-containing membrane vesicles. J Biol Chem 272 (1997) 22987-22990
127. Kakio A., Nishimoto S.I., Yanagisawa K., Kozutsumi Y., and Matsuzaki K. Cholesterol-dependent formation of GM1 ganglioside-bound amyloid β-protein, an endogenous seed for Alzheimer amyloid. J Biol Chem 276 (2001) 24985-24990
128. Rajendran L., Honsho M., Zahn T.R., Keller P., Geiger K.D., Verkade P., et al. Alzheimer's disease β-amyloid peptides are released in association with exosomes. Proc Natl Acad Sci USA 103 (2006) 11172-11177
129. Thery C., Boussac M., Veron P., Ricciardi-Castagnoli P., Raposo G., Garin J., et al. Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J Immunol 166 (2001) 7309-7318
130. de Gassart A., Geminard C., Fevrier B., Raposo G., and Vidal M. Lipid raftassociated protein sorting in exosomes. Blood 102 (2003) 4336-4344
131. Gellermann G.P., Appel T.R., Tannert A., Radestock A., Hortschansky P., Schroeckh V., et al. Raft lipids as common components of human extracellular amyloid fibrils. Proc Natl Acad Sci USA 102 (2005) 6297-6302
132. Carson J.A., and Turner A.J. β-Amyloid catabolism: roles for neprilysin (NEP) and other metallopeptidases?. J Neurochem 81 (2002) 1-8
133. Ledesma M.D., da Silva J.S., Crassaerts K., Delacourte A., De Strooper B., and Dotti C.G. Brain plasmin enhances APP α-cleavage and Aβ degradation and is reduced in Alzheimer's disease brains. EMBO Rep 1 (2000) 530-535
134. Hama E., Shirotani K., Iwata N., and Saido T.C. Effects of neprilysin chimeric proteins targeted to subcellular compartments on amyloid beta peptide clearance in primary neurons. J Biol Chem 279 (2004) 30259-30264
135. Grimm M.O., Grimm H.S., Patzold A.J., Zinser E.G., Halonen R., Duering M., et al. Regulation of cholesterol and sphingomyelin metabolism by amyloid-β and presenilin. Nat Cell Biol 7 (2005) 1118-1123